Anti-Smith Antibodies
EstablishedAnti-Sm is a highly specific but insensitive autoantibody marker for lupus.
Anti-Sm is a specific blood marker for lupus. If it's positive, lupus is very likely, but a negative test doesn't rule it out since many lupus patients never develop this particular antibody.
Anti-Smith (anti-Sm) antibodies target small nuclear ribonucleoproteins and are highly specific autoantibodies associated with systemic lupus erythematosus (SLE), though they occur in only a minority of SLE patients.
Presence of anti-Sm strongly supports an SLE diagnosis due to its high specificity, though its sensitivity is low; it is one of two "SLE-specific antibody" markers (with anti-dsDNA) in current classification criteria.
Measured via immunoassay as part of an extractable nuclear antigen (ENA) panel; the 2019 EULAR/ACR SLE classification criteria require a positive ANA (≥1:80) as a mandatory entry criterion before anti-Sm or anti-dsDNA can contribute additional points toward classification.
Anti-Sm status does not typically guide specific treatment choices but supports diagnostic certainty and is used in research classification of SLE cohorts and clinical trial eligibility.
One of two SLE-specific serologic markers in current classification criteria (with anti-dsDNA).
- Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology.